Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro W Keiserman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Pediatric Infectious Disease Journal|October 28, 2009
Yellow fever vaccination and Kawasaki diseaseDeonilson Schmöeller, Mauro W Keiserman, Henrique Luiz Staub, et al.
Rheumatology International|October 15, 2009
Lupoid sclerosisBriele Keiserman, Luiz Fernando Garcias da Silva, Mauro W Keiserman, et al.
Revista Brasileira De Reumatologia|April 20, 2011
[Immunosuppression with cyclophosphamide and fudarabine, with support of autologous CD-34+ stem cells, in the treatment of severe scleroderma]Carlos Alberto von Mühlen, Everton Luís Hinterholz, Bernardo Garicochea, et al.
Rheumatology and Therapy|April 29, 2021
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 StudyPhilip J Mease, Apinya Lertratanakul, Kim A Papp, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Pediatric Infectious Disease Journal|October 28, 2009
Yellow fever vaccination and Kawasaki diseaseDeonilson Schmöeller, Mauro W Keiserman, Henrique Luiz Staub, et al.
Rheumatology International|October 15, 2009
Lupoid sclerosisBriele Keiserman, Luiz Fernando Garcias da Silva, Mauro W Keiserman, et al.
Revista Brasileira De Reumatologia|April 20, 2011
[Immunosuppression with cyclophosphamide and fudarabine, with support of autologous CD-34+ stem cells, in the treatment of severe scleroderma]Carlos Alberto von Mühlen, Everton Luís Hinterholz, Bernardo Garicochea, et al.
Rheumatology and Therapy|April 29, 2021
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 StudyPhilip J Mease, Apinya Lertratanakul, Kim A Papp, et al.
Pageof 1